Year: 2024
Type: article
Abstract: Over the previous decade, the digital healthcare industry's venture capital has doubled, rising from $4.5 billion with 298 transactions in 2014 to $10.7 billion with 498 deals in 2023.According to the World Economic Forum, global health spending reached $9.8 trillion in 2021 alone, accounting for 10.3% of global GDP at the time.[1,2].As the result of the elevating demand in healthcare services and understaffed medical institutions, consequently, it attracts innovative technologies into the field, such as virtual reality (VR), telemedicine 2.0, machine learning, and, of course, artificial intelligence (AI).Since artificial intelligence transforms eHealth, it has become primarily adopted into medical practice, largely within disease diagnostics, remote patient monitoring (complementary to EMR data, IoT systems, mobile wearables, etc.), hospital resource planning, and customer support chatbots.By the application of deep learning tools, AI gained most recognition in image-based diagnosis, which sourced startups with ideas to level up radiology, dermatology, ophthalmology, pathology, and mental health treatment.[3].Though emerging technologies have been steadily growing their impact on clinical expertise, it is clear that the usefulness of AI in early-stage innovative projects involving such precise topics as health is still understudied and requires further research.Hence, this abstract is aimed at analyzing the latest fundings of AI effectiveness in healthcare startup development through identification of its pros and cons.Despite obvious advantages in applying AI and ML technologies in startups, it does not take away certain entry barriers in integrating them straight into the medical field.The rising concerns involve scarcity in knowledge on health care systems and procurement protocols, underexamined AI usage frameworks, competition with larger medical companies, requirements in pre-deployment focus group interviews, and insufficient resources in maintenance of long-lasting projects that demonstrate both financial and clinical ROI, and so on.[3].Essentially, healthcare startups are composed of differentiated stakeholders, such as patients, healthcare providers, payers, final consumers, medical institutions, and regulators.As they deal with human lives directly, it is resulting in even more challenges to comply with governmental regulations, such as data privacy, compliance with healthcare interoperability standards, direct-to-consumer advertising restrictions, etc. Customers might be rigid in accepting innovations due to the fear factor and the unpredictability of the final results of AI integration in their treatment process, that cause a lengthier sales cycle, on average undertaken within 13 months.[3].Likewise, LLM (Large Language Model) imposes constraints in data security and AI hallucinations, which may cause issues in patient treatment and even damage startup brand image.In addition, cross-sectional observational analysis highlights that many digital health startups have limited clinical validation, with an average clinical robustness score of 2.5 from 10 points out of 224 companies studied.[4].Therefore, the complexity of AI healthcare startup upkeep makes it more difficult to generate revenue, deliver value for the client, and eventually scale up in the long term.On the flip side, the use of AI in digital healthcare companies has the potential to boost four startup areas: service, organization, technology, and finance.[5, p. 3].If the health care enterprise redesigns its business model, AI integration could significantly reduce operational
Authors: Petrenko, Z. O., Samus, P. O.
Language: English
Subfield: Health Informatics
Field: Medicine
Domain: Health Sciences
Keywords: artificial intelligence in healthcare, healthcare startups, AI adoption barriers, data privacy, healthcare interoperability, large language models, AI hallucination, data security, telemedicine, remote patient monitoring, radiology, startup financing, stakeholder acceptance, return on investment, sales cycle
Open Access status: green
OpenAlex ID: W7198332855
